Back to top

Sandoz takes steps to resolve U.S. generic medicine pricing litigation

Sandoz (SDZNY) announces several steps to further resolve the US Generic Drug Antitrust Pricing Litigation. Sandoz and its subsidiary Fougera Pharm...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sandoz Group AG Sponsored ADR (SDZNY)